nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—CA1—Erythrocytes take up carbon dioxide and release oxygen—HBA2—type 2 diabetes mellitus	0.014	0.409	CbGpPWpGaD
Methocarbamol—CA1—Erythrocytes take up carbon dioxide and release oxygen—HBA1—type 2 diabetes mellitus	0.00715	0.209	CbGpPWpGaD
Methocarbamol—Carvedilol—GJA1—type 2 diabetes mellitus	0.00575	0.162	CrCbGaD
Methocarbamol—Carvedilol—NPPB—type 2 diabetes mellitus	0.00575	0.162	CrCbGaD
Methocarbamol—Carvedilol—HIF1A—type 2 diabetes mellitus	0.00436	0.123	CrCbGaD
Methocarbamol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.00421	0.119	CrCbGaD
Methocarbamol—Carvedilol—ADRB3—type 2 diabetes mellitus	0.0026	0.0734	CrCbGaD
Methocarbamol—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00221	0.00238	CcSEcCtD
Methocarbamol—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.0022	0.00236	CcSEcCtD
Methocarbamol—Leukopenia—Glyburide—type 2 diabetes mellitus	0.00218	0.00235	CcSEcCtD
Methocarbamol—Insomnia—Glimepiride—type 2 diabetes mellitus	0.00218	0.00235	CcSEcCtD
Methocarbamol—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.00218	0.00234	CcSEcCtD
Methocarbamol—Jaundice—Irbesartan—type 2 diabetes mellitus	0.00216	0.00232	CcSEcCtD
Methocarbamol—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.00215	0.00231	CcSEcCtD
Methocarbamol—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00215	0.00231	CcSEcCtD
Methocarbamol—Nausea—Nateglinide—type 2 diabetes mellitus	0.00215	0.00231	CcSEcCtD
Methocarbamol—Bradycardia—Metformin—type 2 diabetes mellitus	0.00214	0.0023	CcSEcCtD
Methocarbamol—Shock—Bromocriptine—type 2 diabetes mellitus	0.00214	0.0023	CcSEcCtD
Methocarbamol—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00214	0.0023	CcSEcCtD
Methocarbamol—Felbamate—CYP2E1—type 2 diabetes mellitus	0.00214	0.0603	CrCbGaD
Methocarbamol—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00213	0.00229	CcSEcCtD
Methocarbamol—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.00212	0.00228	CcSEcCtD
Methocarbamol—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.00212	0.00228	CcSEcCtD
Methocarbamol—Convulsion—Glyburide—type 2 diabetes mellitus	0.00211	0.00227	CcSEcCtD
Methocarbamol—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00209	0.00225	CcSEcCtD
Methocarbamol—Pain—Sitagliptin—type 2 diabetes mellitus	0.00206	0.00221	CcSEcCtD
Methocarbamol—Urticaria—Glipizide—type 2 diabetes mellitus	0.00205	0.00221	CcSEcCtD
Methocarbamol—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00204	0.00219	CcSEcCtD
Methocarbamol—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00203	0.00219	CcSEcCtD
Methocarbamol—Jaundice—Losartan—type 2 diabetes mellitus	0.00203	0.00218	CcSEcCtD
Methocarbamol—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.00202	0.00218	CcSEcCtD
Methocarbamol—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00202	0.00217	CcSEcCtD
Methocarbamol—Confusional state—Glyburide—type 2 diabetes mellitus	0.00201	0.00216	CcSEcCtD
Methocarbamol—Angioedema—Gliclazide—type 2 diabetes mellitus	0.002	0.00215	CcSEcCtD
Methocarbamol—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00199	0.00214	CcSEcCtD
Methocarbamol—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00199	0.00214	CcSEcCtD
Methocarbamol—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00198	0.00213	CcSEcCtD
Methocarbamol—Propranolol—ADRB3—type 2 diabetes mellitus	0.00198	0.0558	CrCbGaD
Methocarbamol—Rash—Repaglinide—type 2 diabetes mellitus	0.00197	0.00212	CcSEcCtD
Methocarbamol—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.00197	0.00212	CcSEcCtD
Methocarbamol—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.00197	0.00212	CcSEcCtD
Methocarbamol—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00197	0.00212	CcSEcCtD
Methocarbamol—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00197	0.00212	CcSEcCtD
Methocarbamol—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00196	0.00211	CcSEcCtD
Methocarbamol—Headache—Repaglinide—type 2 diabetes mellitus	0.00196	0.0021	CcSEcCtD
Methocarbamol—Shock—Glyburide—type 2 diabetes mellitus	0.00196	0.0021	CcSEcCtD
Methocarbamol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00195	0.0021	CcSEcCtD
Methocarbamol—Flushing—Metformin—type 2 diabetes mellitus	0.00195	0.0021	CcSEcCtD
Methocarbamol—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.00195	0.00209	CcSEcCtD
Methocarbamol—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00194	0.00208	CcSEcCtD
Methocarbamol—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.00192	0.00207	CcSEcCtD
Methocarbamol—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00192	0.00206	CcSEcCtD
Methocarbamol—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00192	0.00206	CcSEcCtD
Methocarbamol—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00191	0.00205	CcSEcCtD
Methocarbamol—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00191	0.00205	CcSEcCtD
Methocarbamol—Convulsion—Gliclazide—type 2 diabetes mellitus	0.0019	0.00204	CcSEcCtD
Methocarbamol—Vision blurred—Valsartan—type 2 diabetes mellitus	0.0019	0.00204	CcSEcCtD
Methocarbamol—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00187	0.00201	CcSEcCtD
Methocarbamol—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00186	0.002	CcSEcCtD
Methocarbamol—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00186	0.002	CcSEcCtD
Methocarbamol—Hypotension—Glyburide—type 2 diabetes mellitus	0.00186	0.002	CcSEcCtD
Methocarbamol—Nausea—Repaglinide—type 2 diabetes mellitus	0.00186	0.002	CcSEcCtD
Methocarbamol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00185	0.00199	CcSEcCtD
Methocarbamol—Flushing—Irbesartan—type 2 diabetes mellitus	0.00184	0.00198	CcSEcCtD
Methocarbamol—Angioedema—Valsartan—type 2 diabetes mellitus	0.00184	0.00198	CcSEcCtD
Methocarbamol—Pruritus—Glipizide—type 2 diabetes mellitus	0.00183	0.00197	CcSEcCtD
Methocarbamol—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00183	0.00196	CcSEcCtD
Methocarbamol—Angioedema—Orlistat—type 2 diabetes mellitus	0.00182	0.00195	CcSEcCtD
Methocarbamol—Vertigo—Valsartan—type 2 diabetes mellitus	0.00181	0.00194	CcSEcCtD
Methocarbamol—Syncope—Valsartan—type 2 diabetes mellitus	0.0018	0.00194	CcSEcCtD
Methocarbamol—Confusional state—Gliclazide—type 2 diabetes mellitus	0.0018	0.00194	CcSEcCtD
Methocarbamol—Dysgeusia—Metformin—type 2 diabetes mellitus	0.00179	0.00193	CcSEcCtD
Methocarbamol—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00179	0.00193	CcSEcCtD
Methocarbamol—Vertigo—Orlistat—type 2 diabetes mellitus	0.00179	0.00192	CcSEcCtD
Methocarbamol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00178	0.00191	CcSEcCtD
Methocarbamol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00177	0.00191	CcSEcCtD
Methocarbamol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00177	0.0019	CcSEcCtD
Methocarbamol—Carvedilol—VEGFA—type 2 diabetes mellitus	0.00176	0.0496	CrCbGaD
Methocarbamol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00175	0.00189	CcSEcCtD
Methocarbamol—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00175	0.00188	CcSEcCtD
Methocarbamol—Jaundice—Ramipril—type 2 diabetes mellitus	0.00174	0.00187	CcSEcCtD
Methocarbamol—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.00174	0.00187	CcSEcCtD
Methocarbamol—Flushing—Losartan—type 2 diabetes mellitus	0.00173	0.00186	CcSEcCtD
Methocarbamol—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00173	0.00186	CcSEcCtD
Methocarbamol—Vision blurred—Metformin—type 2 diabetes mellitus	0.00173	0.00186	CcSEcCtD
Methocarbamol—Convulsion—Orlistat—type 2 diabetes mellitus	0.00172	0.00185	CcSEcCtD
Methocarbamol—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00172	0.00185	CcSEcCtD
Methocarbamol—Dizziness—Glipizide—type 2 diabetes mellitus	0.00171	0.00184	CcSEcCtD
Methocarbamol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00171	0.00184	CcSEcCtD
Methocarbamol—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.00169	0.00182	CcSEcCtD
Methocarbamol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00167	0.0018	CcSEcCtD
Methocarbamol—Vomiting—Glipizide—type 2 diabetes mellitus	0.00164	0.00177	CcSEcCtD
Methocarbamol—Syncope—Metformin—type 2 diabetes mellitus	0.00164	0.00177	CcSEcCtD
Methocarbamol—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00164	0.00176	CcSEcCtD
Methocarbamol—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00164	0.00176	CcSEcCtD
Methocarbamol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00164	0.00176	CcSEcCtD
Methocarbamol—Rash—Glipizide—type 2 diabetes mellitus	0.00163	0.00175	CcSEcCtD
Methocarbamol—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00163	0.00175	CcSEcCtD
Methocarbamol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00163	0.00175	CcSEcCtD
Methocarbamol—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00162	0.00174	CcSEcCtD
Methocarbamol—Headache—Glipizide—type 2 diabetes mellitus	0.00162	0.00174	CcSEcCtD
Methocarbamol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00162	0.00174	CcSEcCtD
Methocarbamol—Shock—Valsartan—type 2 diabetes mellitus	0.00162	0.00174	CcSEcCtD
Methocarbamol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00161	0.00173	CcSEcCtD
Methocarbamol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.0016	0.00172	CcSEcCtD
Methocarbamol—Dysgeusia—Losartan—type 2 diabetes mellitus	0.00159	0.00171	CcSEcCtD
Methocarbamol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00159	0.00171	CcSEcCtD
Methocarbamol—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00159	0.00171	CcSEcCtD
Methocarbamol—Urticaria—Glyburide—type 2 diabetes mellitus	0.00158	0.0017	CcSEcCtD
Methocarbamol—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00158	0.0017	CcSEcCtD
Methocarbamol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00157	0.00169	CcSEcCtD
Methocarbamol—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00155	0.00167	CcSEcCtD
Methocarbamol—Headache—Pioglitazone—type 2 diabetes mellitus	0.00155	0.00167	CcSEcCtD
Methocarbamol—Syncope—Irbesartan—type 2 diabetes mellitus	0.00155	0.00167	CcSEcCtD
Methocarbamol—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00155	0.00166	CcSEcCtD
Methocarbamol—Nausea—Glipizide—type 2 diabetes mellitus	0.00154	0.00165	CcSEcCtD
Methocarbamol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00153	0.00165	CcSEcCtD
Methocarbamol—Hypotension—Valsartan—type 2 diabetes mellitus	0.00153	0.00165	CcSEcCtD
Methocarbamol—Vision blurred—Losartan—type 2 diabetes mellitus	0.00153	0.00165	CcSEcCtD
Methocarbamol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00153	0.00164	CcSEcCtD
Methocarbamol—Pain—Gliclazide—type 2 diabetes mellitus	0.00153	0.00164	CcSEcCtD
Methocarbamol—Rash—Glimepiride—type 2 diabetes mellitus	0.00152	0.00164	CcSEcCtD
Methocarbamol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00152	0.00163	CcSEcCtD
Methocarbamol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00152	0.00163	CcSEcCtD
Methocarbamol—Rash—Sitagliptin—type 2 diabetes mellitus	0.00152	0.00163	CcSEcCtD
Methocarbamol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00152	0.00163	CcSEcCtD
Methocarbamol—Headache—Glimepiride—type 2 diabetes mellitus	0.00151	0.00163	CcSEcCtD
Methocarbamol—Headache—Sitagliptin—type 2 diabetes mellitus	0.00151	0.00162	CcSEcCtD
Methocarbamol—Flushing—Ramipril—type 2 diabetes mellitus	0.00149	0.0016	CcSEcCtD
Methocarbamol—Angioedema—Losartan—type 2 diabetes mellitus	0.00149	0.0016	CcSEcCtD
Methocarbamol—Insomnia—Valsartan—type 2 diabetes mellitus	0.00149	0.0016	CcSEcCtD
Methocarbamol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00147	0.00158	CcSEcCtD
Methocarbamol—Shock—Metformin—type 2 diabetes mellitus	0.00147	0.00158	CcSEcCtD
Methocarbamol—Insomnia—Orlistat—type 2 diabetes mellitus	0.00147	0.00158	CcSEcCtD
Methocarbamol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00147	0.00158	CcSEcCtD
Methocarbamol—Vertigo—Losartan—type 2 diabetes mellitus	0.00146	0.00157	CcSEcCtD
Methocarbamol—Somnolence—Valsartan—type 2 diabetes mellitus	0.00146	0.00157	CcSEcCtD
Methocarbamol—Syncope—Losartan—type 2 diabetes mellitus	0.00146	0.00157	CcSEcCtD
Methocarbamol—Leukopenia—Losartan—type 2 diabetes mellitus	0.00146	0.00157	CcSEcCtD
Methocarbamol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00145	0.00155	CcSEcCtD
Methocarbamol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00144	0.00155	CcSEcCtD
Methocarbamol—Nausea—Glimepiride—type 2 diabetes mellitus	0.00143	0.00154	CcSEcCtD
Methocarbamol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00143	0.00154	CcSEcCtD
Methocarbamol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00143	0.00154	CcSEcCtD
Methocarbamol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00143	0.00154	CcSEcCtD
Methocarbamol—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00142	0.00153	CcSEcCtD
Methocarbamol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00141	0.00152	CcSEcCtD
Methocarbamol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00141	0.00152	CcSEcCtD
Methocarbamol—Pruritus—Glyburide—type 2 diabetes mellitus	0.00141	0.00151	CcSEcCtD
Methocarbamol—Hypotension—Metformin—type 2 diabetes mellitus	0.0014	0.0015	CcSEcCtD
Methocarbamol—Shock—Irbesartan—type 2 diabetes mellitus	0.00139	0.00149	CcSEcCtD
Methocarbamol—Pain—Orlistat—type 2 diabetes mellitus	0.00139	0.00149	CcSEcCtD
Methocarbamol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00138	0.00149	CcSEcCtD
Methocarbamol—Rash—Bromocriptine—type 2 diabetes mellitus	0.00137	0.00148	CcSEcCtD
Methocarbamol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00137	0.00147	CcSEcCtD
Methocarbamol—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00137	0.00147	CcSEcCtD
Methocarbamol—Headache—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00147	CcSEcCtD
Methocarbamol—Felbamate—CYP3A4—type 2 diabetes mellitus	0.00135	0.038	CrCbGaD
Methocarbamol—Confusional state—Losartan—type 2 diabetes mellitus	0.00134	0.00144	CcSEcCtD
Methocarbamol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00134	0.00144	CcSEcCtD
Methocarbamol—Somnolence—Metformin—type 2 diabetes mellitus	0.00133	0.00143	CcSEcCtD
Methocarbamol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00133	0.00143	CcSEcCtD
Methocarbamol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00132	0.00142	CcSEcCtD
Methocarbamol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00132	0.00142	CcSEcCtD
Methocarbamol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00132	0.00141	CcSEcCtD
Methocarbamol—Shock—Losartan—type 2 diabetes mellitus	0.00131	0.0014	CcSEcCtD
Methocarbamol—Urticaria—Valsartan—type 2 diabetes mellitus	0.0013	0.0014	CcSEcCtD
Methocarbamol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00129	0.00139	CcSEcCtD
Methocarbamol—Urticaria—Orlistat—type 2 diabetes mellitus	0.00129	0.00139	CcSEcCtD
Methocarbamol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00128	0.00138	CcSEcCtD
Methocarbamol—Angioedema—Ramipril—type 2 diabetes mellitus	0.00127	0.00137	CcSEcCtD
Methocarbamol—Vomiting—Glyburide—type 2 diabetes mellitus	0.00127	0.00136	CcSEcCtD
Methocarbamol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00126	0.00136	CcSEcCtD
Methocarbamol—Rash—Glyburide—type 2 diabetes mellitus	0.00126	0.00135	CcSEcCtD
Methocarbamol—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00125	0.00135	CcSEcCtD
Methocarbamol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00125	0.00135	CcSEcCtD
Methocarbamol—Vertigo—Ramipril—type 2 diabetes mellitus	0.00125	0.00135	CcSEcCtD
Methocarbamol—Syncope—Ramipril—type 2 diabetes mellitus	0.00125	0.00134	CcSEcCtD
Methocarbamol—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00125	0.00134	CcSEcCtD
Methocarbamol—Headache—Glyburide—type 2 diabetes mellitus	0.00125	0.00134	CcSEcCtD
Methocarbamol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00124	0.00134	CcSEcCtD
Methocarbamol—Hypotension—Losartan—type 2 diabetes mellitus	0.00124	0.00133	CcSEcCtD
Methocarbamol—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00123	0.00132	CcSEcCtD
Methocarbamol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00123	0.00132	CcSEcCtD
Methocarbamol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00121	0.0013	CcSEcCtD
Methocarbamol—Convulsion—Ramipril—type 2 diabetes mellitus	0.00121	0.0013	CcSEcCtD
Methocarbamol—Pain—Irbesartan—type 2 diabetes mellitus	0.00121	0.0013	CcSEcCtD
Methocarbamol—Insomnia—Losartan—type 2 diabetes mellitus	0.0012	0.00129	CcSEcCtD
Methocarbamol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.0012	0.00128	CcSEcCtD
Methocarbamol—Urticaria—Metformin—type 2 diabetes mellitus	0.00119	0.00128	CcSEcCtD
Methocarbamol—Nausea—Glyburide—type 2 diabetes mellitus	0.00118	0.00127	CcSEcCtD
Methocarbamol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00118	0.00127	CcSEcCtD
Methocarbamol—Somnolence—Losartan—type 2 diabetes mellitus	0.00118	0.00127	CcSEcCtD
Methocarbamol—Carvedilol—ADRA2A—type 2 diabetes mellitus	0.00118	0.0332	CrCbGaD
Methocarbamol—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00117	0.00126	CcSEcCtD
Methocarbamol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00116	0.00125	CcSEcCtD
Methocarbamol—Pruritus—Valsartan—type 2 diabetes mellitus	0.00116	0.00125	CcSEcCtD
Methocarbamol—Confusional state—Ramipril—type 2 diabetes mellitus	0.00115	0.00123	CcSEcCtD
Methocarbamol—Pruritus—Orlistat—type 2 diabetes mellitus	0.00115	0.00123	CcSEcCtD
Methocarbamol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00114	0.00122	CcSEcCtD
Methocarbamol—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00114	0.00122	CcSEcCtD
Methocarbamol—Pain—Losartan—type 2 diabetes mellitus	0.00114	0.00122	CcSEcCtD
Methocarbamol—Rash—Gliclazide—type 2 diabetes mellitus	0.00113	0.00121	CcSEcCtD
Methocarbamol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00113	0.00121	CcSEcCtD
Methocarbamol—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00112	0.0012	CcSEcCtD
Methocarbamol—Shock—Ramipril—type 2 diabetes mellitus	0.00112	0.0012	CcSEcCtD
Methocarbamol—Headache—Gliclazide—type 2 diabetes mellitus	0.00112	0.0012	CcSEcCtD
Methocarbamol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00112	0.0012	CcSEcCtD
Methocarbamol—Ranolazine—CYP3A4—type 2 diabetes mellitus	0.0011	0.031	CrCbGaD
Methocarbamol—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00109	0.00118	CcSEcCtD
Methocarbamol—Dizziness—Valsartan—type 2 diabetes mellitus	0.00109	0.00117	CcSEcCtD
Methocarbamol—Dizziness—Orlistat—type 2 diabetes mellitus	0.00107	0.00115	CcSEcCtD
Methocarbamol—Hypotension—Ramipril—type 2 diabetes mellitus	0.00106	0.00114	CcSEcCtD
Methocarbamol—Nausea—Gliclazide—type 2 diabetes mellitus	0.00106	0.00114	CcSEcCtD
Methocarbamol—Pruritus—Metformin—type 2 diabetes mellitus	0.00106	0.00114	CcSEcCtD
Methocarbamol—Urticaria—Losartan—type 2 diabetes mellitus	0.00106	0.00113	CcSEcCtD
Methocarbamol—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00105	0.00113	CcSEcCtD
Methocarbamol—Vomiting—Valsartan—type 2 diabetes mellitus	0.00104	0.00112	CcSEcCtD
Methocarbamol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00104	0.00112	CcSEcCtD
Methocarbamol—Rash—Valsartan—type 2 diabetes mellitus	0.00104	0.00111	CcSEcCtD
Methocarbamol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00103	0.00111	CcSEcCtD
Methocarbamol—Vomiting—Orlistat—type 2 diabetes mellitus	0.00103	0.00111	CcSEcCtD
Methocarbamol—Insomnia—Ramipril—type 2 diabetes mellitus	0.00103	0.00111	CcSEcCtD
Methocarbamol—Headache—Valsartan—type 2 diabetes mellitus	0.00103	0.00111	CcSEcCtD
Methocarbamol—Rash—Orlistat—type 2 diabetes mellitus	0.00102	0.0011	CcSEcCtD
Methocarbamol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00102	0.0011	CcSEcCtD
Methocarbamol—Headache—Orlistat—type 2 diabetes mellitus	0.00102	0.00109	CcSEcCtD
Methocarbamol—Somnolence—Ramipril—type 2 diabetes mellitus	0.00101	0.00109	CcSEcCtD
Methocarbamol—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.001	0.00108	CcSEcCtD
Methocarbamol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000998	0.00107	CcSEcCtD
Methocarbamol—Dizziness—Metformin—type 2 diabetes mellitus	0.000989	0.00106	CcSEcCtD
Methocarbamol—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000978	0.00105	CcSEcCtD
Methocarbamol—Nausea—Valsartan—type 2 diabetes mellitus	0.000975	0.00105	CcSEcCtD
Methocarbamol—Nausea—Orlistat—type 2 diabetes mellitus	0.000964	0.00104	CcSEcCtD
Methocarbamol—Vomiting—Metformin—type 2 diabetes mellitus	0.000951	0.00102	CcSEcCtD
Methocarbamol—Rash—Metformin—type 2 diabetes mellitus	0.000943	0.00101	CcSEcCtD
Methocarbamol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000942	0.00101	CcSEcCtD
Methocarbamol—Pruritus—Losartan—type 2 diabetes mellitus	0.00094	0.00101	CcSEcCtD
Methocarbamol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000938	0.00101	CcSEcCtD
Methocarbamol—Headache—Metformin—type 2 diabetes mellitus	0.000937	0.00101	CcSEcCtD
Methocarbamol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000933	0.001	CcSEcCtD
Methocarbamol—Urticaria—Ramipril—type 2 diabetes mellitus	0.000905	0.000972	CcSEcCtD
Methocarbamol—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.0009	0.000968	CcSEcCtD
Methocarbamol—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000897	0.000964	CcSEcCtD
Methocarbamol—Rash—Irbesartan—type 2 diabetes mellitus	0.00089	0.000956	CcSEcCtD
Methocarbamol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000889	0.000955	CcSEcCtD
Methocarbamol—Nausea—Metformin—type 2 diabetes mellitus	0.000888	0.000955	CcSEcCtD
Methocarbamol—Headache—Irbesartan—type 2 diabetes mellitus	0.000884	0.00095	CcSEcCtD
Methocarbamol—Dizziness—Losartan—type 2 diabetes mellitus	0.000878	0.000944	CcSEcCtD
Methocarbamol—Carvedilol—CYP2E1—type 2 diabetes mellitus	0.00086	0.0243	CrCbGaD
Methocarbamol—Vomiting—Losartan—type 2 diabetes mellitus	0.000844	0.000908	CcSEcCtD
Methocarbamol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000839	0.000902	CcSEcCtD
Methocarbamol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000838	0.000901	CcSEcCtD
Methocarbamol—Rash—Losartan—type 2 diabetes mellitus	0.000837	0.0009	CcSEcCtD
Methocarbamol—Dermatitis—Losartan—type 2 diabetes mellitus	0.000837	0.000899	CcSEcCtD
Methocarbamol—Headache—Losartan—type 2 diabetes mellitus	0.000832	0.000894	CcSEcCtD
Methocarbamol—Carvedilol—CYP1A2—type 2 diabetes mellitus	0.000818	0.0231	CrCbGaD
Methocarbamol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000806	0.000866	CcSEcCtD
Methocarbamol—Nausea—Losartan—type 2 diabetes mellitus	0.000789	0.000848	CcSEcCtD
Methocarbamol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000753	0.000809	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—GSTM1—type 2 diabetes mellitus	0.000744	0.0218	CbGpPWpGaD
Methocarbamol—Vomiting—Ramipril—type 2 diabetes mellitus	0.000724	0.000778	CcSEcCtD
Methocarbamol—Rash—Ramipril—type 2 diabetes mellitus	0.000718	0.000772	CcSEcCtD
Methocarbamol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000717	0.000771	CcSEcCtD
Methocarbamol—Headache—Ramipril—type 2 diabetes mellitus	0.000713	0.000767	CcSEcCtD
Methocarbamol—Nausea—Ramipril—type 2 diabetes mellitus	0.000676	0.000727	CcSEcCtD
Methocarbamol—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000622	0.0176	CrCbGaD
Methocarbamol—Carvedilol—CYP3A4—type 2 diabetes mellitus	0.000541	0.0153	CrCbGaD
Methocarbamol—CA1—C-MYB transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000449	0.0131	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—BCL2—type 2 diabetes mellitus	0.000442	0.0129	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—PTGS2—type 2 diabetes mellitus	0.00042	0.0123	CbGpPWpGaD
Methocarbamol—Propranolol—CYP3A4—type 2 diabetes mellitus	0.000412	0.0116	CrCbGaD
Methocarbamol—CA1—Metabolism—BHMT—type 2 diabetes mellitus	0.00032	0.00936	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—AANAT—type 2 diabetes mellitus	0.00028	0.00818	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PTGDS—type 2 diabetes mellitus	0.00028	0.00818	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GPD2—type 2 diabetes mellitus	0.000265	0.00776	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CDO1—type 2 diabetes mellitus	0.000265	0.00776	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—AK1—type 2 diabetes mellitus	0.000253	0.0074	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—MAT1A—type 2 diabetes mellitus	0.000233	0.00683	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000233	0.00683	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HBA2—type 2 diabetes mellitus	0.000225	0.0066	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—G6PC—type 2 diabetes mellitus	0.000225	0.0066	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ENPP1—type 2 diabetes mellitus	0.000225	0.0066	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ND1—type 2 diabetes mellitus	0.000225	0.0066	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000225	0.0066	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GCGR—type 2 diabetes mellitus	0.000218	0.00639	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYTB—type 2 diabetes mellitus	0.000206	0.00603	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—OXCT1—type 2 diabetes mellitus	0.000206	0.00603	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000201	0.00588	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ACACA—type 2 diabetes mellitus	0.000192	0.00561	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000192	0.00561	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—STAR—type 2 diabetes mellitus	0.000192	0.00561	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CBS—type 2 diabetes mellitus	0.000184	0.00538	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ABCC8—type 2 diabetes mellitus	0.000184	0.00538	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—COX2—type 2 diabetes mellitus	0.000177	0.00518	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000177	0.00518	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NCOA6—type 2 diabetes mellitus	0.000174	0.00508	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—UCP3—type 2 diabetes mellitus	0.000171	0.005	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—UCP2—type 2 diabetes mellitus	0.000171	0.005	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000171	0.005	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PCK1—type 2 diabetes mellitus	0.000161	0.0047	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HK1—type 2 diabetes mellitus	0.00015	0.0044	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000145	0.00425	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000145	0.00425	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—LPA—type 2 diabetes mellitus	0.000145	0.00425	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GCKR—type 2 diabetes mellitus	0.000145	0.00425	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ALDOB—type 2 diabetes mellitus	0.000139	0.00407	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GLP1R—type 2 diabetes mellitus	0.000129	0.00379	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000121	0.00354	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—MTR—type 2 diabetes mellitus	0.000118	0.00346	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CPT1A—type 2 diabetes mellitus	0.000118	0.00346	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NAMPT—type 2 diabetes mellitus	0.000116	0.0034	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GCK—type 2 diabetes mellitus	0.000115	0.00338	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—LIPC—type 2 diabetes mellitus	0.000115	0.00338	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HBA1—type 2 diabetes mellitus	0.000115	0.00338	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000115	0.00336	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000113	0.0033	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CETP—type 2 diabetes mellitus	0.000111	0.00326	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SREBF1—type 2 diabetes mellitus	0.000104	0.00303	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PSMD6—type 2 diabetes mellitus	0.000104	0.00303	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SNAP25—type 2 diabetes mellitus	0.000104	0.00303	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CTGF—type 2 diabetes mellitus	0.000102	0.00297	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HMGCR—type 2 diabetes mellitus	0.000101	0.00295	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.86e-05	0.00288	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP2E1—type 2 diabetes mellitus	9.47e-05	0.00277	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC2A1—type 2 diabetes mellitus	9.36e-05	0.00274	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP1A2—type 2 diabetes mellitus	9.36e-05	0.00274	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.13e-05	0.00267	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.98e-05	0.00263	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GCG—type 2 diabetes mellitus	8.98e-05	0.00263	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GNB3—type 2 diabetes mellitus	7.74e-05	0.00226	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.74e-05	0.00226	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HMOX1—type 2 diabetes mellitus	7.7e-05	0.00225	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CAT—type 2 diabetes mellitus	7.6e-05	0.00222	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—APOB—type 2 diabetes mellitus	7.38e-05	0.00216	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GSTM1—type 2 diabetes mellitus	7.18e-05	0.0021	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—LPL—type 2 diabetes mellitus	7.04e-05	0.00206	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ADCY5—type 2 diabetes mellitus	6.9e-05	0.00202	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GPX1—type 2 diabetes mellitus	6.87e-05	0.00201	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CD36—type 2 diabetes mellitus	6.69e-05	0.00196	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.61e-05	0.00193	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—MTHFR—type 2 diabetes mellitus	6.34e-05	0.00186	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PPARA—type 2 diabetes mellitus	6.22e-05	0.00182	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—AGT—type 2 diabetes mellitus	6.03e-05	0.00176	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CALM1—type 2 diabetes mellitus	5.92e-05	0.00173	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—APOE—type 2 diabetes mellitus	5.9e-05	0.00173	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—APOA1—type 2 diabetes mellitus	5.84e-05	0.00171	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PPARG—type 2 diabetes mellitus	5.14e-05	0.0015	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—INS—type 2 diabetes mellitus	5.04e-05	0.00148	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ALB—type 2 diabetes mellitus	4.62e-05	0.00135	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NOS3—type 2 diabetes mellitus	4.42e-05	0.00129	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.42e-05	0.00129	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	4.05e-05	0.00118	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—AKT1—type 2 diabetes mellitus	2.03e-05	0.000595	CbGpPWpGaD
